This paper reviews the past, present, and future of the hydroxyapatite (HAp)-based biomaterials from the point of view of preparation of hard tissue replacement implants. Properties of the hard tissues are also described. The mechanical reliability of the pure HAp ceramics is low, therefore it cannot be used as artificial teeth or bones. For these reasons, various HAp-based composites have been fabricated, but only the HAp-coated titanium alloys have found wide application. Among the others, the microstructurally controlled HAp ceramics such as fibers/whiskers-reinforced HAp, fibrous HAp-reinforced polymers, or biomimetically fabricated HAp/collagen composites seem to be the most suitable ceramic materials for the future hard tissue replacement implants.

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0884291400042527

Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants

Use of clays as drug delivery systems: Possibilities and limitations

Clay minerals and layered double hydroxides for novel biological applications

Recent advances in high intensity focused ultrasound (HIFU), which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100 000 cases have been treated throughout the world with great success. The fundamental principles of HIFU ablation are coagulative thermal necrosis due to the absorption of ultrasound energy during transmission in tissue and the induced cavitation damage. This paper reviews the clinical outcomes of HIFU ablation for applicable cancers, and then summarizes the recommendations for a satisfactory HIFU treatment according to clinical experience. In addition, the current challenges in HIFU for engineers and physicians are also included. More recent horizons have broadened the application of HIFU in tumor treatment, such as HIFU-mediated drug delivery, vessel occlusion, and soft tissue erosion (“histotripsy”). In summary, HIFU is likely to play a significant role in the future oncology practice.

High intensity focused ultrasound in clinical tumor ablation

Nano-sized hydroxyapatite (HA) particles were prepared by chemical precipitation through aqueous solutions of calcium chloride and ammonium hydrogenphosphate. The influence of temperature, ripening time and calcination on the crystallinity and morphology of the HA nanoparticles were investigated. It was found that the crystallinity and crystallite size increased with the increase of synthetic temperature and ripening time. XRD and TEM results showed that the morphology change of HA nanoparticles was related to their crystallinity. High crystallinity of HA led to regular shape and smooth surface of the nanoparticles. The crystallinity of HA powders increased greatly after calcination at 650 °C for 6 h but the change of the crystallite size after calcination was dependent on the crystallinity and crystallite size of “as prepared” HA nanoparticles.

Influence of temperature, ripening time and calcination on the morphology and crystallinity of hydroxyapatite nanoparticles

A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier

https://scholars.lib.ntu.edu.tw/bitstream/123456789/83520/1/07.pdf

Mechanical properties and histological evaluation of sintered β-Ca2P2O7 with Na4P2O7 · 10H2O addition

The authors discuss a two-model multilayer neural network controller for adaptive control of mean arterial blood pressure (MABP) using sodium nitroprusside. A model with an autoregressive moving average (ARMA), representing the dynamics of the system, and a modified backpropagation training algorithm are used to design the control system to meet specified objectives of design (settling time and undershoot/overshoot) and clinical constraints. The controller is associated with a weighting-determinant unit (WDU) to determine and update the output weighting factor of the parallel two-model neural network for adequate control action and a control-signal modification unit (CMU) to comply with clinical constraints and to suppress the effect of adverse noise and to improve the WDU performance. Extensive computer simulations indicate satisfactory performance and robustness of the proposed controller in the presence of much noise, over the full range of plant parameters, uncertainties, and large variations of parameters.

Adaptive control of arterial blood pressure with a learning controller based on multilayer neural networks

Sintered porous DP-bioactive glass and hydroxyapatite as bone substitute.

http://scholars.lib.ntu.edu.tw/bitstream/123456789/83516/1/05.pdf

Cheng-Yi Wang

Papers

A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier

Mechanical properties and histological evaluation of sintered β-Ca2P2O7 with Na4P2O7 · 10H2O addition

Adaptive control of arterial blood pressure with a learning controller based on multilayer neural networks

Sintered porous DP-bioactive glass and hydroxyapatite as bone substitute.

The effects of ultrasonic stimulation on DP-bioglass bone substitute